ASX News Health Care Imugene’s azer-cel trial sees tumours temporarily disappear in 3 of 10 patients Imugene (ASX:IMU) has announced 3 patients in its latest blood cancer treatment trial using azer-cel have… 2 mins02 September 2024 10:14 (AEDT)